XWELL (XWEL) to Release Earnings on Tuesday

XWELL (NASDAQ:XWEL) is expected to announce its Q4 2025 resultson Tuesday, April 21st. Analysts expect the company to announce earnings of ($1.00) per share and revenue of $2.3710 million for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, April 1, 2026 at 7:00 AM ET.

XWELL (NASDAQ:XWEL) last released its quarterly earnings results on Wednesday, April 1st. The company reported ($3.29) EPS for the quarter. XWELL had a negative return on equity of 352.37% and a negative net margin of 58.17%.The company had revenue of $7.15 million for the quarter.

XWELL Trading Down 0.8%

XWEL stock opened at $1.18 on Tuesday. XWELL has a 52 week low of $0.26 and a 52 week high of $2.20. The company has a market capitalization of $9.36 million, a price-to-earnings ratio of -0.23 and a beta of 0.96. The firm’s 50-day moving average is $1.02 and its two-hundred day moving average is $0.84.

Analyst Upgrades and Downgrades

A number of analysts have commented on XWEL shares. Weiss Ratings restated a “sell (e+)” rating on shares of XWELL in a research report on Wednesday, January 21st. Wall Street Zen upgraded shares of XWELL to a “sell” rating in a research report on Saturday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, XWELL presently has an average rating of “Sell”.

XWELL Company Profile

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.